Sex, drugs, and rhetoric: The case of flibanserin for ‘female sexual dysfunction’ (August 2018)
In August, 2015, the US Food and Drug Administration approved Addyi (flibanserin) for the treatment of Hypoactive Sexual Desire Disorder in premenopausal women. Ten months before that, the FDA had held a Patient-Focused Drug Development Public Meeting to address the ‘unmet need’ for a pharmaceutical to treat that condition. I attended that meeting as a rhetorical observer. This essay is an account of persuasive strategies used on, and then by, the FDA, as it considered approving a drug that was not convincingly either safe or effective. The essay turns on three texts: the ‘Even the Score’ pro-drug campaign that informed the patient-focused meeting, the text of the meeting itself, and the FDA’s own published report of the event. I describe how a pharmaceutical company (Sprout, then owners of flibanserin) recruited, and then ventriloquized, both health professionals and members of the public to pressure the FDA to approve a sex drug for women – claiming that not to do so was evidence of sexism. I argue, with rhetorical evidence, that the case for approving flibanserin had already been won before Sprout submitted its application.
...MoreSimilar Citations
Article
Schleifer, David;
(February 2013)
Categories count: Trans fat labeling as a technique of corporate governance
(/isis/citation/CBB214363773/)
Chapter
Daemmrich, A.;
Greene, J.;
(2010)
From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance
(/isis/citation/CBB001221031/)
Article
Sarah Wadmann;
Amalie Martinus Hauge;
(August 2021)
Strategies of stratification: Regulating market access in the era of personalized medicine
(/isis/citation/CBB940730003/)
Article
Rosenberg, John;
(2012)
Barbarian Virtues in a Bottle: Patent Indian Medicines and the Commodification of Primitivism in the United States, 1870--1900
(/isis/citation/CBB001212647/)
Article
Colleen Lanier-Christensen;
(September 2021)
Creating Regulatory Harmony: The Participatory Politics of OECD Chemical Testing Standards in the Making
(/isis/citation/CBB606231580/)
Article
Becky Mansfield;
(2021)
Deregulatory science: Chemical risk analysis in Trump’s EPA
(/isis/citation/CBB234438851/)
Article
Emmanuel Henry;
Valentin Thomas;
Sara Angeli Aguiton;
Marc-Olivier Déplaude;
Nathalie Jas;
(September 2021)
Introduction: Beyond the Production of Ignorance: The Pervasiveness of Industry Influence through the Tools of Chemical Regulation
(/isis/citation/CBB736985993/)
Book
David J. Hess;
(2016)
Undone Science: Social Movements, Mobilized Publics, and Industrial Transitions
(/isis/citation/CBB272081586/)
Article
Philip Olson;
Christine Labuski;
(August 2018)
‘There’s always a [white] man in the loop’: The gendered and racialized politics of civilian drones
(/isis/citation/CBB568832607/)
Article
Jennie L Durant;
(October 2020)
Ignorance loops: How non-knowledge about bee-toxic agrochemicals is iteratively produced
(/isis/citation/CBB459611870/)
Book
Phoebe A. Pollitt;
(2014)
The History of Professional Nursing in North Carolina, 1902-2002
(/isis/citation/CBB646169797/)
Article
George Martin;
(2019)
A Sustainability Interrogation of the Autonomous Vehicle at Its Society-Technology Interface
(/isis/citation/CBB041327262/)
Article
Langston, Nancy;
(January 2018)
DOCUMERICA and the Power of Environmental History
(/isis/citation/CBB114442000/)
Book
David Vogel;
(2018)
California Greenin': How the Golden State Became an Environmental Leader
(/isis/citation/CBB569183355/)
Thesis
Schwartz, Jason Lee;
(2012)
External Factors: Advisory Committees, Regulation, and American Public Health, 1962--1999
(/isis/citation/CBB001567388/)
Article
Kelly Joslin Holloway;
(September 2015)
Normalizing Complaint: Scientists and the Challenge of Commercialization
(/isis/citation/CBB582502078/)
Article
Benjamin K. Sovacool;
M. V. Ramana;
(January 2015)
Back to the Future: Small Modular Reactors, Nuclear Fantasies, and Symbolic Convergence
(/isis/citation/CBB596943703/)
Article
Abby Kinchy;
Guy Schaffer;
(November 2018)
Disclosure Conflicts: Crude Oil Trains, Fracking Chemicals, and the Politics of Transparency
(/isis/citation/CBB796979408/)
Article
Klaus Hoeyer;
(July 2015)
Regulatory Anatomy: How “Safety Logics” Structure European Transplant Medicine
(/isis/citation/CBB387324455/)
Article
Stephens, Neil;
Atkinson, Paul;
Glasner, Peter;
(December 2011)
Documenting the doable and doing the documented: Bridging strategies at the UK Stem Cell Bank
(/isis/citation/CBB128580755/)
Be the first to comment!